Advertising


News

In Practice: Changes to dual-labelled medicine ingredient names


Morgan Liotta


1/05/2025 1:31:46 PM

The TGA has advised that more dual-labelled medicine ingredient names have begun the transition to sole ingredient names. 

Blister pack of small white tablets
A number of medicines with dual-labelled ingredient names moved to sole names on 30 April.

This week’s In Practice also includes details of an upcoming children’s wellbeing webinar, focusing on helping parents to contextualise concerns they have about their children.
 
Dual-labelled ingredient names moving to sole names 
The Therapeutic Goods Administration (TGA) is reminding GPs that more dual-labelled medicine ingredient names began transitioning to sole ingredient names from 30 April. 
 
The dual labelling period for most ingredient names ended on 30 April 2023 and entered a transition period towards showing only new names on medicine labels. For some ingredient names, dual labelling continued for longer.  
 
Ingredient names with longer dual-labelling period ending 30 April 2025 are: 

  • dosulepin (dothiepin) hydrochloride 
  • hydroxycarbamide (hydroxyurea) 
  • tetracaine (amethocaine) 
  • tetracaine (amethocaine) hydrochloride 
  • trihexyphenidyl (benzhexol) hydrochloride.
The TGA is reminding GPs to be aware when prescribing, dispensing, and administering medicines to ensure they choose the right product, and to remind patients to speak to their doctor if they see an ingredient name they do not recognise or have questions about ingredients in medicines. 
 
More information is available on the TGA website
 
Laying the foundation for focused psychological strategies for children 
Webinar: Thursday 8 May, 7.00 – 8.30 pm (AEST) 
CPD: 1.5 EA hour 
Register online 
 
Presented by RACGP Specific Interests and Emerging Minds, this webinar will support participants to consider several skills in engagement and assessment with children and their families. It focuses on engaging with parents to explore their values and contextualise the concerns they have about their children’s wellbeing.
 
In addition, the webinar will cover initial engagement skills for working directly with children, including exploring children’s own values and how a whole-child approach can be applied to existing assessment processes to gain the most holistic picture of the child’s presenting concerns. 
 
Log in below to join the conversation. 
 


children’s health focused psychological strategies medication regulation medicine ingredients TGA


newsGP weekly poll As a GP, do you use any resources or visit a healthcare professional to support your own mental health and wellbeing?
 
38%
 
60%
 
1%
Related



newsGP weekly poll As a GP, do you use any resources or visit a healthcare professional to support your own mental health and wellbeing?

Advertising

Advertising

 

Login to comment